William Schaffner - Concepedia

Author

William Schaffner

Also Known As

Barbara Resnick, Berkeley Picciotto, Christina B. Felsen, Dieter Groschel, Eli Shiltz, Erin Licherdell, James McAuley, Kevin Popham, Laurie Billing, Laurie M. Billing

717

Publications

39.6K

Citations

H-Index

293

Concepts

All Affiliations

Vanderbilt University Centers for Disease Control and Prevention Minnesota Department of Health Emory University Colorado Department of Public Health and Environment

About

William Schaffner is an author at Vanderbilt University specializing in medicine, infection control, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	17	19	2.5K
2	Arts	2	2	338
3	Education	2	2	92
4	Engineering	2	2	50
5	Humanities	2	2	22

William Schaffner

368

Publications

36.3K

Citations

H-Index

Page 1

	Year	Citations
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 Shikha Garg, Lindsay Kim, Michael Whitaker, MMWR Morbidity and Mortality Weekly Report	2020	2.4K
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine Tamara Pilishvili, Catherine Lexau, Monica M. Farley, The Journal of Infectious Diseases	2009	1.3K
Psychotropic Drug Use and the Risk of Hip Fracture Wayne A. Ray, Marie R. Griffin, William Schaffner, New England Journal of Medicine Substance AbusePsychoactive DrugSubstance UseHip FracturesPsychiatry	1987	1K
Bacterial Meningitis in the United States, 1998–2007 Michael C. Thigpen, Cynthia G. Whitney, Nancy E. Messonnier, New England Journal of Medicine VaccinationVaccine SafetyBacterial InfectionsPreventive MedicineMedicine	2011	940
Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant <i>Streptococcus pneumoniae</i> Moe H. Kyaw, Ruth Lynfield, William Schaffner, New England Journal of Medicine	2006	873
Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004 Lauri A. Hicks, Lee H. Harrison, Brendan Flannery, The Journal of Infectious Diseases	2007	742
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance Matthew R. Moore, Ruth Link‐Gelles, William Schaffner, The Lancet Infectious Diseases VaccinationVaccinologyInvasive Pneumococcal DiseasePreventive MedicinePediatric Epidemiology	2015	716
Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) Lindsay Kim, Shikha Garg, Alissa O’Halloran, Clinical Infectious Diseases	2020	667
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study Cynthia G. Whitney, Tamar Pilishvili, Monica M. Farley, The Lancet VaccinationVaccinologyInvasive Pneumococcal DiseaseImmunologyVaccine Efficacy	2006	622
Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1–July 25, 2020 Lindsay Kim, Michael Whitaker, Alissa O’Halloran, MMWR Morbidity and Mortality Weekly Report	2020	522

Page 1